Invention Grant
- Patent Title: Composition for cancer prevention or treatment containing as active ingredient plant stem cell line dervied from cambium of Panax ginseng including wild ginseng or ginseng
- Patent Title (中): 含有作为活性成分的癌症预防或治疗组合物植物干细胞系由人参人参或人参的形成层衍生而来
-
Application No.: US13127750Application Date: 2009-11-06
-
Publication No.: US09314492B2Publication Date: 2016-04-19
- Inventor: Young Woo Jin , Eun Kyong Lee
- Applicant: Young Woo Jin , Eun Kyong Lee
- Applicant Address: KR Jeonju-Si, Jeollabuk-Do KR Jeonju-Si, Jeollabuk-Do KR Jeonju-Si, Jeollabuk-Do
- Assignee: UNHWA CORPORATION,Young Woo Jin,Eun Kyoung Lee
- Current Assignee: UNHWA CORPORATION,Young Woo Jin,Eun Kyoung Lee
- Current Assignee Address: KR Jeonju-Si, Jeollabuk-Do KR Jeonju-Si, Jeollabuk-Do KR Jeonju-Si, Jeollabuk-Do
- Agency: Moore & Van Allen, PLLC
- Agent Tristan A. Fuierer
- Priority: KR10-2008-0110086 20081106
- International Application: PCT/KR2009/006523 WO 20091106
- International Announcement: WO2010/053314 WO 20100514
- Main IPC: A01N65/00
- IPC: A01N65/00 ; A61K36/258 ; A01H4/00 ; A23L1/30 ; C12N5/04

Abstract:
The present invention relates to a composition for preventing or treating cancer, which contains, as an active ingredient, a Panax ginseng cambium-derived cell line including wild ginseng or ginseng; a lysate thereof; an extract thereof; or a culture medium thereof, which are derived from a natural and have minimized side effects compared to the conventional therapeutic drugs, and thus are safe for the human body. Also, they are involved directly in the growth of cancer to induce cancer cell death effectively, and show anticancer activity of inhibiting or reducing the formation of tumor or the growth of tumor.
Public/Granted literature
Information query